Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerrit Meijer

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Gastroenterology|October 3, 2002
Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instabilityMario Hermsen, Cindy Postma, Jan Baak, et al.
International Journal of Cancer|December 13, 2016
Assessing opportunities for coordinated R&D in early cancer detection and management in EuropeAnton E Ussi, Matejka Rebolj, Mangesh A Thorat, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancerJulien Vincenten, Egbert F Smit, Wim Vos, et al.
Neuro-Oncology|February 16, 2017
Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomasKhalil Abou-El-Ardat, Michael Seifert, Kerstin Becker, et al.
Nature Communications|March 25, 2026
TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matchingMajd Abdallah, Sigve Nakken, Mikaël Georges, et al.
Cancer Research|June 4, 2008
Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target geneKumaresan Ganesan, Tatiana Ivanova, Yonghui Wu, et al.
The Journal of Pathology|March 28, 2012
Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancerJoana Carvalho, Nicole C van Grieken, Patricia M Pereira, et al.
The Journal of Pathology|February 10, 2022
The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathwaysArne Gc Bleijenberg, Joep Eg IJspeert, Jos Bg Mulder, et al.
Nature Reviews. Drug Discovery|April 29, 2017
Bridging the translational innovation gap through good biomarker practiceAlain J van Gool, Florence Bietrix, Eric Caldenhoven, et al.
Clinical and Translational Science|April 3, 2021
A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotypeMarina Baretti, Enusha Karunasena, Marianna Zahurak, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Gastroenterology|October 3, 2002
Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instabilityMario Hermsen, Cindy Postma, Jan Baak, et al.
International Journal of Cancer|December 13, 2016
Assessing opportunities for coordinated R&D in early cancer detection and management in EuropeAnton E Ussi, Matejka Rebolj, Mangesh A Thorat, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancerJulien Vincenten, Egbert F Smit, Wim Vos, et al.
Neuro-Oncology|February 16, 2017
Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomasKhalil Abou-El-Ardat, Michael Seifert, Kerstin Becker, et al.
Nature Communications|March 25, 2026
TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matchingMajd Abdallah, Sigve Nakken, Mikaël Georges, et al.
Cancer Research|June 4, 2008
Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target geneKumaresan Ganesan, Tatiana Ivanova, Yonghui Wu, et al.
The Journal of Pathology|March 28, 2012
Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancerJoana Carvalho, Nicole C van Grieken, Patricia M Pereira, et al.
The Journal of Pathology|February 10, 2022
The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathwaysArne Gc Bleijenberg, Joep Eg IJspeert, Jos Bg Mulder, et al.
Nature Reviews. Drug Discovery|April 29, 2017
Bridging the translational innovation gap through good biomarker practiceAlain J van Gool, Florence Bietrix, Eric Caldenhoven, et al.
Clinical and Translational Science|April 3, 2021
A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotypeMarina Baretti, Enusha Karunasena, Marianna Zahurak, et al.
Pageof 3